Breast Cancer News and Research

Latest Breast Cancer News and Research

Researchers examine effects of ACA on cancer survivors

In 2010, the total cost of cancer care in the United States reached $125 billion. Globally, the economic toll from cancer is nearly 20 percent higher than the leading cause of death, heart disease. Cancer patients are also living longer today, which is further increasing the cost of their continued care.

24 Jan 2014

Moderate radiation doses can kill premalignant cells and prevent second breast cancers

Survivors of breast cancer have a one in six chance of developing breast cancer in the other breast. But a study conducted in mice suggests that survivors can dramatically reduce that risk through treatment with moderate doses of radiation to the unaffected breast at the same time that they receive radiation therapy to their affected breast.

24 Jan 2014

Scientists develop mathematical model to predict tumor behavior and personalized therapies

Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient's tumor is likely to behave and which of several possible treatments is most likely to be effective.

24 Jan 2014

USF Health and FORCE receive award from PCORI to develop and expand health data network

A team led by the University of South Florida (USF Health) Morsani College of Medicine and the leading national hereditary breast and ovarian cancer advocacy organization, FORCE (Facing Our Risk of Cancer Empowered), has received a $960,026 award from the Patient-Centered Outcomes Research Institute (PCORI) to develop and expand a health data network that will be part of PCORnet: the National Patient-Centered National Clinical Research Network.

24 Jan 2014

OBGYN.net to present new research and topics related to cervical health

UBM Medica US announces that OBGYN.net, a leading online community for medical professionals specializing in women's health, will present new research and topics over the coming weeks related to cervical cancer and cervical health in honor of January being Cervical Health Awareness Month.

23 Jan 2014

New tools to increase precision and safety of radiation treatment in cancer patients

A scientific breakthrough may give the field of radiation oncology new tools to increase the precision and safety of radiation treatment in cancer patients by helping doctors "see" the powerful beams of a linear accelerator as they enter or exit the body.

23 Jan 2014

Study identify key barriers associated with lack of cancer screenings in Appalachian women

A new study by University of Kentucky researchers shows that women who never or rarely screen for breast cancer are also unlikely to receive screening for cervical cancer. The study also identified four key barriers independently associated with the lack of these cancer screenings in Appalachian women.

23 Jan 2014

MD Anderson collaborates with Johnson & Johnson to develop immunology-based cancer treatments

The University of Texas MD Anderson Cancer Center will collaborate with Johnson & Johnson Innovation, LLC, and its affiliate Janssen Biotech, Inc., to develop immunology-based cancer treatments through the MD Anderson Moon Shots Program immunotherapy platform.

23 Jan 2014

Hydroxytyrosol in olive oil may help reduce risk of breast cancer

A major component of olive oil, hydroxytyrosol, is the subject of a Houston Methodist study of women who are at increased risk of developing breast cancer. The study focuses on the changes in breast density after one year of treatment and is the first of its kind in the United States.

23 Jan 2014

NCCC physicians use new gene sequencing equipment for testing abnormal DNA in cancerous tumor cells

Clinical laboratory experts and physicians at Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC) achieved 100 percent accuracy in testing for abnormal DNA in cancerous tumor cells with its new gene sequencing equipment and panels.

23 Jan 2014

Girls treated for Hodgkin's disease during adolescence acquire risk of developing breast cancer

Girls treated for Hodgkin's disease during adolescence acquire a considerable risk of developing breast cancer, as shown by an observational study published in the current issue of Deutsches Ärzteblatt International.

22 Jan 2014

Viewpoints: High Court's scrutiny of home health workers law; patient 'dumping' on LA's skid row; hospital fund raising

On Tuesday the Supreme Court will hear arguments in Harris v. Quinn, ... It was brought by the National Right to Work Legal Defense Foundation (NRTW), whose mission is to use "strategic litigation" to "eliminate coercive union power and compulsory unionism abuses," in this case on behalf of several personal assistants who provide in-home services to persons with disabilities under Illinois's Medicaid program.

22 Jan 2014

Role of folate in development, progression of breast cancer highly controversial

Folic acid supplements at levels consumed by breast cancer patients and survivors in North America promoted the growth of existing breast cancer in rats, new research found.

21 Jan 2014

Damon Runyon Cancer Research Foundation awards $2.25M to six innovative young scientists

The Damon Runyon Cancer Research Foundation announced that six scientists with novel approaches to fighting cancer have been named 2014 recipients of the Damon Runyon-Rachleff Innovation Award. The grant of $450,000 over three years is awarded each year to early career scientists whose projects have the potential to significantly impact the prevention, diagnosis and treatment of cancer.

21 Jan 2014

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Advaxis, Inc., a leader in developing the next generation of cancer immunotherapies, announced that the first patient has been dosed in a Phase 1/2 "window of opportunity" study being conducted by the Icahn School of Medicine at Mount Sinai. Patients diagnosed with HPV-associated head and neck cancer will receive ADXS-HPV immunotherapy during the "window" of time between initial diagnosis and minimally invasive transoral robotic surgery to remove their tumors.

21 Jan 2014

EBCC-9: Most exciting breast cancer conference in Europe

The most exciting breast cancer conference in Europe, it is the only one that involves all the major players in breast cancer. The conference encourages interaction and collaboration between clinicians, scientists and patients in a partnership of equals to talk not just about scientific advances, but also the ethical, social, political, and practical issues associated with caring for patients with breast cancer. EBCC-9 is expected to attract around 5000 delegates from around 90 countries worldwide.

20 Jan 2014

Pulmonary Fibrosis Foundation selects UofL for newly established Care Center Network

The University of Louisville is one of nine pilot sites selected by the Pulmonary Fibrosis Foundation for its newly established Care Center Network and the PFF Patient Registry program. Rafael Perez, M.D., director of the UofL Interstitial Lung Disease program in the Division of Pulmonary, Critical Care & Sleep Disorders Medicine, will lead the UofL site.

17 Jan 2014

Research findings could lead to life-saving treatments to fight tumor metastasis

A team of researchers from the Cleveland Clinic and Case Western Reserve School of Medicine have identified critical complex mechanisms involved in the metastasis of deadly "triple negative" breast cancers. These tumors are extremely difficult to treat, frequently return after remission, and are the most aggressive form of breast cancer in women. The discovery of this critical interaction of mechanisms could be used to develop new life saving treatments to kill metastatic tumors in TNBC.

17 Jan 2014

Different subtypes of HER2+ breast cancer facilitate more effective treatment tailored to specific tumor

Research led by the Translational Genomics Group at Vall d'Hebron Institute of Oncology (VHIO) in Barcelona has not only shown that HER2+ breast cancer can be classified into four different subtypes, but also unmasked a subtype showing both a greater response to and increased benefit from chemotherapy and anti-HER2 therapy.

17 Jan 2014

Three new spin-offs emerged from Helmholtz Zentrum München

Three new spin-offs emerged from Helmholtz Zentrum München (HMGU) in 2013: SurgVision, Trianta Immunotherapies and Dosimetrics. Thanks to successful innovation management, the Center has transformed excellent research findings into practical applications and given new impulses to the areas of clinical imaging, immunotherapy and radiation dosimetry.

17 Jan 2014

Breast Cancer News and Research

Latest Breast Cancer News and Research

Researchers examine effects of ACA on cancer survivors

Moderate radiation doses can kill premalignant cells and prevent second breast cancers

Scientists develop mathematical model to predict tumor behavior and personalized therapies

USF Health and FORCE receive award from PCORI to develop and expand health data network

OBGYN.net to present new research and topics related to cervical health

New tools to increase precision and safety of radiation treatment in cancer patients

Study identify key barriers associated with lack of cancer screenings in Appalachian women

MD Anderson collaborates with Johnson & Johnson to develop immunology-based cancer treatments

Hydroxytyrosol in olive oil may help reduce risk of breast cancer

NCCC physicians use new gene sequencing equipment for testing abnormal DNA in cancerous tumor cells

Girls treated for Hodgkin's disease during adolescence acquire risk of developing breast cancer

Viewpoints: High Court's scrutiny of home health workers law; patient 'dumping' on LA's skid row; hospital fund raising

Role of folate in development, progression of breast cancer highly controversial

Damon Runyon Cancer Research Foundation awards $2.25M to six innovative young scientists

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

EBCC-9: Most exciting breast cancer conference in Europe

Pulmonary Fibrosis Foundation selects UofL for newly established Care Center Network

Research findings could lead to life-saving treatments to fight tumor metastasis

Different subtypes of HER2+ breast cancer facilitate more effective treatment tailored to specific tumor

Three new spin-offs emerged from Helmholtz Zentrum München

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in